Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
RATIONALE: Respiratory syncytial virus (RSV) induces not only infantile recurrent wheezing but also potentially atopic asthma. OBJECTIVES: To test the effect of RSV infection on development of subsequent atopic asthma, we evaluated whether palivizumab, an anti-RSV monoclonal antibody, by preventing severe RSV disease in the first year of life, could impact subsequent recurrent wheezing and atopic asthma at 6 years of age. METHODS: During the 2007 to 2008 RSV season, the decision to administer palivizumab was made based on standard medical practice and an observational prospective multicenter (n = 52) case-control study in preterm infants with a gestational age between 33 and 35 weeks followed from 0 to 3 years (preceding Committee on Recurrent Wheezing study). The 52 investigators at hospitals then followed these subjects until 6 years of age, reported here (Effects of Preventive Treatment for Respiratory Syncytial [RS] Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants; Scientific Committee for Elucidation of Infantile Asthma). Parents of study subjects reported the infants' physicians' assessment of recurrent wheezing, using a report card and a novel mobile phone-based reporting system using the Internet. The primary endpoint was the incidence of atopic asthma. MEASUREMENTS AND MAIN RESULTS: Of 444 preterm infants enrolled, 349 received palivizumab during the first year of life. At 6 years, atopic asthma was not different in the groups: 15.3 and 18.2% of infants in the treated and untreated groups, respectively (P = 0.57). On the other hand, physician-diagnosed recurrent wheezing was observed in 15.3 and 31.6% in the treated and untreated groups, respectively (P = 0.003). CONCLUSIONS: Palivizumab prophylaxis administered to preterm infants did not suppress the onset of atopic asthma but resulted in a significantly lower incidence of recurrent wheezing during the first 6 years. Clinical trial registered with www.clinicaltrials.gov (NCT 01545245).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Asthma and Wheezing in the First Six Years of Life
Martinez, F. D., Wright, A. L., Taussig, L. M., Holberg, C. J., Halonen, M., & Morgan, W. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501193320301 · Cited by 3,823
The IMpact-RSV Study Group (1998) · Pediatrics · doi:10.1542/peds.102.3.531 · Cited by 1,961
Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
Stein, R. T., Sherrill, D., Morgan, W. J., Holberg, C. J., Halonen, M., Taussig, L. M., Wright, A. L., & Martinez, F. D. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10321-5 · Cited by 1,633 · cited 2×
“In contrast, other studies suggest that the effect of RSV does not induce atopy but rather causes recurrent wheezing that might last up to 13 years and is not associated with an atopic phenotype (4).”
BackgroundResultSIGURS, N., BJARNASON, R., SIGURBERGSSON, F., & KJELLMAN, B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.5.9906076 · Cited by 1,131 · cited 1×
“The most important advantages of this system include (1) parental follow-up reporting, especially mothers; (2) minimum physician involvement in reporting findings during clinic visits; and (3) conveniently efficient data transfer directly to the research center, which seemingly attracted and motivated mothers.”
BackgroundSevere Respiratory Syncytial Virus Bronchiolitis in Infancy and Asthma and Allergy at Age 13
Sigurs, N., Gustafsson, P. M., Bjarnason, R., Lundberg, F., Schmidt, S., Sigurbergsson, F., & Kjellman, B. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200406-730oc · Cited by 956 · cited 1×
“The most important advantages of this system include (1) parental follow-up reporting, especially mothers; (2) minimum physician involvement in reporting findings during clinic visits; and (3) conveniently efficient data transfer directly to the research center, which seemingly attracted and motivated mothers.”
BackgroundBrand, P. L. P., Baraldi, E., Bisgaard, H., Boner, A. L., Castro-Rodriguez, J. A., Custovic, A., de Blic, J., de Jongste, J. C., Eber, E., Everard, M. L., et al. (2008) · European Respiratory Journal · doi:10.1183/09031936.00002108 · Cited by 857 · cited 1×
“The European Respiratory Society task force has proposed a symptom-based classification that defines episodic wheezing and multitrigger wheeze (30).”
BackgroundA summary of the new GINA strategy: a roadmap to asthma control
Reddel, H. K., Bateman, E. D., Becker, A., Boulet, L.-P., Cruz, A. A., Drazen, J. M., Haahtela, T., Hurd, S. S., Inoue, H., de Jongste, J. C., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.00853-2015 · Cited by 788 · cited 2×
“Finally, the GINA consortium has proposed a probability-based approach to diagnosis of wheezing children, suggesting that in preschool children with symptoms for more than 10 days during viral infections; severe or frequent episodes; interval symptoms during play, laughing, or crying; and with atopy or a family histor…”
BackgroundMethodKusel, M. M. H., de Klerk, N. H., Kebadze, T., Vohma, V., Holt, P. G., Johnston, S. L., & Sly, P. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.669 · Cited by 748
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
Illi, S., von Mutius, E., Lau, S., Niggemann, B., Grüber, C., & Wahn, U. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69286-6 · Cited by 719
Asthma and allergy patterns over 18 years after severe RSV bronchiolitis in the first year of life
Sigurs, N., Aljassim, F., Kjellman, B., Robinson, P. D., Sigurbergsson, F., Bjarnason, R., & Gustafsson, P. M. (2010) · Thorax · doi:10.1136/thx.2009.121582 · Cited by 714 · cited 2×
“Sigurs and colleagues reported that RSV bronchiolitis in infancy is an important risk factor for the later development of asthma and allergy (2), whereas Simões and colleagues (11) reported that RSV prevention by palivizumab prophylaxis in nonatopic children decreased the relative risk of recurrent wheezing.”
BackgroundRespiratory Syncytial Virus and Recurrent Wheeze in Healthy Preterm Infants
Blanken, M. O., Rovers, M. M., Molenaar, J. M., Winkler-Seinstra, P. L., Meijer, A., Kimpen, J. L. L., & Bont, L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211917 · Cited by 671
Johnson, S., Oliver, C., Prince, G. A., Hemming, V. G., Pfarr, D. S., Wang, S., Dormitzer, M., O'Grady, J., Koenig, S., Tamura, J. K., et al. (1997) · The Journal of Infectious Diseases · doi:10.1086/514115 · Cited by 641 · cited 1×
“Palivizumab, a humanized anti-RSV monoclonal antibody that binds to the RSV fusion protein, neutralizes RSV and successfully inhibits viral replication (8).”
BackgroundPullan, C. R., & Hey, E. N. (1982) · BMJ · doi:10.1136/bmj.284.6330.1665 · Cited by 603 · cited 1×
“The ratio of virus-related nonatopic wheeze/asthma and atopic wheeze/asthma might be close to 50:50, as in previous reports (10, 21, 29).”
ResultRespiratory allergy caused by house dust mites: What do we really know?
Calderón, M. A., Linneberg, A., Kleine-Tebbe, J., De Blay, F., Hernandez Fernandez de Rojas, D., Virchow, J. C., & Demoly, P. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.012 · Cited by 553 · cited 1×
“pteronyssinus or Dermatophagoides farinae (34).”
Rhinovirus Wheezing Illness and Genetic Risk of Childhood-Onset Asthma
Çalışkan, M., Bochkov, Y. A., Kreiner-Møller, E., Bønnelykke, K., Stein, M. M., Du, G., Bisgaard, H., Jackson, D. J., Gern, J. E., Lemanske, R. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211592 · Cited by 544
Henderson, J., Granell, R., Heron, J., Sherriff, A., Simpson, A., Woodcock, A., Strachan, D. P., Shaheen, S. O., & Sterne, J. A. C. (2008) · Thorax · doi:10.1136/thx.2007.093187 · Cited by 530 · cited 1×
“It has been suggested that RSV infection not only exacerbates asthma attacks but also is involved in the inception of asthma (13, 21).”
BackgroundPreterm Birth and Childhood Wheezing Disorders: A Systematic Review and Meta-Analysis
Been, J. V., Lugtenberg, M. J., Smets, E., van Schayck, C. P., Kramer, B. W., Mommers, M., & Sheikh, A. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001596 · Cited by 376 · cited 1×
“A metaanalysis of the relationship between wheezing disorders and gestational age suggests that preterm birth, particularly very preterm birth, results in higher rates of wheezing than term infants (25).”
BackgroundHenderson, J., Hilliard, T. N., Sherriff, A., Stalker, D., Shammari, N. A., Thomas, H. M., & the ALSPAC Study Team (2005) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2005.00298.x · Cited by 365
Comparison of childhood wheezing phenotypes in 2 birth cohorts: ALSPAC and PIAMA
Savenije, O. E., Granell, R., Caudri, D., Koppelman, G. H., Smit, H. A., Wijga, A., de Jongste, J. C., Brunekreef, B., Sterne, J. A., Postma, D. S., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.02.002 · Cited by 351
Early identification of atopy in the prediction of persistent asthma in children
Sly, P. D., Boner, A. L., Björksten, B., Bush, A., Custovic, A., Eigenmann, P. A., Gern, J. E., Gerritsen, J., Hamelmann, E., Helms, P. J., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61451-8 · Cited by 347
Palivizumab Prophylaxis, Respiratory Syncytial Virus, and Subsequent Recurrent Wheezing
Simoes, E. A. F., Groothuis, J. R., Carbonell-Estrany, X., Rieger, C. H. L., Mitchell, I., Fredrick, L. M., & Kimpen, J. L. L. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.02.032 · Cited by 305 · cited 4×
“The ratio of virus-related nonatopic wheeze/asthma and atopic wheeze/asthma might be close to 50:50, as in previous reports (10, 21, 29).”
BackgroundResultInfluentialRespiratory Syncytial Virus Infection in Infants Is Associated with Predominant Th-2-like Response
ROMÁN, M., CALHOUN, W. J., HINTON, K. L., AVENDAÑO, L. F., SIMON, V., ESCOBAR, A. M., GAGGERO, A., & DÍAZ, P. V. (1997) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.156.1.9611050 · Cited by 303 · cited 2×
“The observation that infantile RSV infection induces a predominantly Th2 response to airway allergens supports this suggestion (7, 22).”
BackgroundThe effects of respiratory infections, atopy, and breastfeeding on childhood asthma
Oddy, W. H., de Klerk, N. H., Sly, P. D., & Holt, P. G. (2002) · European Respiratory Journal · doi:10.1183/09031936.02.00103602 · Cited by 263
Exposure to dust mite allergen and endotoxin in early life and asthma and atopy in childhood
Celedón, J. C., Milton, D. K., Ramsey, C. D., Litonjua, A. A., Ryan, L., Platts-Mills, T. A. E., & Gold, D. R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.03.037 · Cited by 248 · cited 1×
“pteronyssinus (37), to the inclusion of three measures of IgE sensitization (38), to those that include skin prick tests and very comprehensive measures, including up to 14 specific IgE tests (1, 4, 13, 35, 39–43).”
BackgroundRhodes, H. L., Thomas, P., Sporik, R., Holgate, S. T., & Cogswell, J. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.2104032 · Cited by 229
Simões, E. A. F., Carbonell-Estrany, X., Rieger, C. H. L., Mitchell, I., Fredrick, L., & Groothuis, J. R. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.05.026 · Cited by 221 · cited 6×
“These results are consistent with that of our earlier CREW study (12) as well as the earlier European studies (10, 11, 27) and strongly suggest a reduction of recurrent wheezing by RSV prophylaxis that persists up to at least 6 years.”
InfluentialSelf-citationThe Childhood Origins of Asthma (COAST) study
Lemanske, R. F. (2002) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.13.s.15.8.x · Cited by 220 · cited 2×
“The ratio of virus-related nonatopic wheeze/asthma and atopic wheeze/asthma might be close to 50:50, as in previous reports (10, 21, 29).”
BackgroundResultBertrand, J.-M., Riley, S. P., Popkin, J., & Coates, A. L. (1985) · New England Journal of Medicine · doi:10.1056/nejm198503213121202 · Cited by 211 · cited 1×
“Premature infants have airway prematurity, which induces persistent bronchial hyperresponsiveness (24).”
BackgroundDistinguishing phenotypes of childhood wheeze and cough using latent class analysis
Spycher, B. D., Silverman, M., Brooke, A. M., Minder, C. E., & Kuehni, C. E. (2008) · European Respiratory Journal · doi:10.1183/09031936.00153507 · Cited by 193
O'Brien, K. L., Chandran, A., Weatherholtz, R., Jafri, H. S., Griffin, M. P., Bellamy, T., Millar, E. V., Jensen, K. M., Harris, B. S., Reid, R., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00247-9 · Cited by 190
Savenije, O. E., Mahachie John, J. M., Granell, R., Kerkhof, M., Dijk, F. N., de Jongste, J. C., Smit, H. A., Brunekreef, B., Postma, D. S., Van Steen, K., et al. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.12.1080 · Cited by 185
Clinical and Epidemiologic Features of Respiratory Syncytial Virus
Hall, C. B., Simőes, E. A. F., & Anderson, L. J. (2013) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-38919-1_2 · Cited by 182 · cited 1×
“Palivizumab, an anti–RSV fusion protein monoclonal antibody, is used to prevent serious RSV disease in preterm infants and those with congenital heart disease (23).”
BackgroundSelf-citationJafri, H. S., Chávez‐Bueno, S., Mejías, A., Gómez, A. M., Ríos, A. M., Nassi, S. S., Yusuf, M., Kapur, P., Hardy, R. D., Hatfield, J., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/386372 · Cited by 170 · cited 1×
“RSV is a leading cause of serious LRI in infants and induces persistent airway damage and bronchial hyperresponsiveness (20).”
BackgroundTLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization
Caballero, M. T., Serra, M. E., Acosta, P. L., Marzec, J. M., Gibbons, L., Salim, M., Rodríguez, A., Reynaldi, A., García, A. G., Bado, D., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci75183 · Cited by 159 · cited 1×
“The observation that infantile RSV infection induces a predominantly Th2 response to airway allergens supports this suggestion (7, 22).”
BackgroundEffect of Palivizumab Prophylaxis on Subsequent Recurrent Wheezing in Preterm Infants
Yoshihara, S., Kusuda, S., Mochizuki, H., Okada, K., Nishima, S., & Simões, E. A. F. (2013) · PEDIATRICS · doi:10.1542/peds.2013-0982 · Cited by 146 · cited 9×
“These results are consistent with that of our earlier CREW study (12) as well as the earlier European studies (10, 11, 27) and strongly suggest a reduction of recurrent wheezing by RSV prophylaxis that persists up to at least 6 years.”
BackgroundMethodResultInfluentialSelf-citationStensballe, L. G., Ravn, H., Kristensen, K., Agerskov, K., Meakins, T., Aaby, P., & Simões, E. A. F. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.10.043 · Cited by 133 · cited 1×
“Maternal asthma confers a five- to sixfold higher risk for RSV hospitalization in Danish infants up to 18 months of age (31).”
BackgroundSelf-citationSchultz, A., Devadason, S. G., Savenije, O. E. M., Sly, P. D., Souëf, P. N. L., & Brand, P. L. P. (2009) · Acta Paediatrica · doi:10.1111/j.1651-2227.2009.01508.x · Cited by 118
Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort
Tovey, E. R., Almqvist, C., Li, Q., Crisafulli, D., & Marks, G. B. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.05.010 · Cited by 102 · cited 1×
“pteronyssinus (37), to the inclusion of three measures of IgE sensitization (38), to those that include skin prick tests and very comprehensive measures, including up to 14 specific IgE tests (1, 4, 13, 35, 39–43).”
BackgroundImpact of Wheezing After Respiratory Syncytial Virus Infection on Health-Related Quality of Life
Bont, L., Steijn, M., van Aalderen, W. M. C., & Kimpen, J. L. L. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000122604.32137.29 · Cited by 76
Markers of Impaired Growth of Pulmonary Function in Children and Adolescents
ULRIK, C. S., & Backer, V. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.1.9806059 · Cited by 59 · cited 1×
“Thus, a cohort of children with atopy to house dust mite had lower lung function than those who were unsensitized (35).”
BackgroundMinami, T., Fukutomi, Y., Lidholm, J., Yasueda, H., Saito, A., Sekiya, K., Tsuburai, T., Maeda, Y., Mori, A., Taniguchi, M., et al. (2014) · Allergology International · doi:10.1016/j.alit.2014.08.004 · Cited by 41 · cited 1×
“pteronyssinus were highly predictive of an immediate allergic response to bronchoprovocation (36).”
BackgroundPreterm Birth with Childhood Asthma: The Role of Degree of Prematurity and Asthma Definitions
He, H., Butz, A. M., Keet, C. A., Minkovitz, C. S., Hong, X., Caruso, D., Pearson, C., Cohen, R. T., Wills-Karp, M. A., ZUCKERMAN, B. S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201503-0522le · Cited by 37 · cited 1×
“Compared with infants born at full term, early preterm infants have the highest odds of developing later asthma, but late preterm infants have the second highest odds (26).”
BackgroundKaneko, M., Watanabe, J., Ueno, E., Hida, M., & Sone, T. (2001) · Pediatrics International · doi:10.1046/j.1442-200x.2001.01438.x · Cited by 32 · cited 11×
“The rates of the family history of allergy/atopy in the European/Canadian study, 220 of 421 (52%), were not dissimilar to our in study in Japan, 250 of 440 (57%).”
BackgroundInfluential
Cited by
After asthma: redefining airways diseases
Pavord, I. D., Beasley, R., Agusti, A., Anderson, G. P., Bel, E., Brusselle, G., Cullinan, P., Custovic, A., Ducharme, F. M., Fahy, J. V., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)30879-6 · Cited by 1,073
Role of viral infections in the development and exacerbation of asthma in children
Jartti, T., & Gern, J. E. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.08.003 · Cited by 474
Kulkarni, P. S., Hurwitz, J. L., Simões, E. A. F., & Piedra, P. A. (2018) · Viral Immunology · doi:10.1089/vim.2017.0147 · Cited by 53
Self-citationThe environmental microbiome, allergic disease, and asthma
Kelly, M. S., Bunyavanich, S., Phipatanakul, W., & Lai, P. S. (2022) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2022.06.006 · Cited by 47
Altman, M. C., Beigelman, A., Ciaccio, C., Gern, J. E., Heymann, P. W., Jackson, D. J., Kennedy, J. L., Kloepfer, K., Lemanske, R. F., McWilliams, L. M., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.12.904 · Cited by 37
Metadata
- Authors
- Mochizuki, H., Kusuda, S., Okada, K., Yoshihara, S., Furuya, H., Simões, E. A. F., Asanuma, H., Yoshida, H., Katayose, M., Imamura, T., Suzumura, H., Honma, Y., Medical, J., Maruyama, K., Ohki, Y., Ozasa, K., Nariai, A., Uchiyama, A., Uryu, H., Hosono, S., Kondo, M., Kawase, Y., Ikeda, K., Ikeda, K., Naito, A., Minami, Y., Nakamura, T., Baba, A., Nagayama, Y., Kaneda, H., Ohki, S., Shiraii, M., Henmi, Y., Suzuki, C., Ieda, K., Tanaka, T., Kono, Y., Nisizawa, K., Niwa, F., Ito, H., Tokunaga, Y., Takada, Y., Nishikawa, Y., Nagata, I., Kajino, Y., Watabe, S., Yoshio, H., Takahashi, N., Sasaki, N., Hayashidani, M., Tateishi, H., Matsushita, K., Nakamura, M., Nakayama, H., Yamamoto, G., Kanemitsu, N., Takayanagi, T., Sato, A., & Ibara, S.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-01
- Volume
- 196
- Issue
- 1
- Pages
- 29-38
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2586644068
- Cited by
- 173
- References
- 43
- FWCI
- 17.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.